All News #Library
Biotech
Crossbow Therapeutics Raises $77M for Cancer Antibody Therapies
18 Mar 2026 //
PHARMIWEB
Crossbow Therapeutics Doses 1st Patient in Ph 1 Trial of CBX-250
16 Sep 2025 //
PHARMAWEB
Crossbow Picks CBX-663 for Solid and Blood Cancer Treatment
23 Jul 2025 //
BUSINESSWIRE

Market Place
Sourcing Support